Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹3 Cr
Revenue (TTM)
₹41 Cr
Net Profit (TTM)
₹0 Cr
ROE
2.1 %
ROCE
4.6 %
P/E Ratio
18.7
P/B Ratio
0.1
Industry P/E
20.67
EV/EBITDA
6.2
Div. Yield
0 %
Debt to Equity
0.2
Book Value
₹--
EPS
₹0.1
Face value
10
Shares outstanding
27,918,406
CFO
-35.71 Cr
EBITDA
16.06 Cr
Net Profit
6.69 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
BSE Commodities
| -4.9 | -8.2 | -6.3 | 5.0 | 15.1 | 11.3 | 15.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
No Review & Analysis are available.
Manufacture of pesticides and other agrochemical products
Incorporated
1995
Chairman
K Balakrishna Rao
Managing Director
K T Vijay Kumar
Headquarters
Vijayawada, Andhra Pradesh
Website
Looking for more details about Chemcel Biotech Ltd.’s IPO? Explore our IPO Details page.
Annual Reports
The P/E ratio of Chemcel Biotech Ltd is 18.68 times as on 20-Mar-2013, a 10 discount to its peers’ median range of 20.67 times.
The P/B ratio of Chemcel Biotech Ltd is 0.06 times as on 20-Mar-2013, a 96 discount to its peers’ median range of 1.54 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2011
|
16.56
|
0.33
|
|
2010
|
16.16
|
0.55
|
|
2009
|
12.69
|
0.43
|
|
2008
|
0.00
|
0.00
|
|
2007
|
0.00
|
0.00
|
The 52-week high and low of Chemcel Biotech Ltd are Rs -- and Rs -- as of 02-Apr-2026.
Chemcel Biotech Ltd has a market capitalisation of ₹ 3 Cr as on 20-Mar-2013. As per SEBI classification, it is a company.
Before investing in Chemcel Biotech Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.